PATIENT’S DATA DIAGNOSTIC TEST

PATHOPHYSIOLOGY
 PATIENT: F.V  COLONOSCOPY
 64 YEAR’S OLD  BIOPSY
 MALE  MOLECULAR TESTING
 MARRIED OF THE TUMOR
 HE HAS 4 ADULT CHILDREN  BLOOD TESTS
 COMPUTED
TOMOGRAPHY (CT OR
CAT) SCAN
 MAGNETIC
SIGNIFICANT DATA
RESONANCE
 SMOKER FOR 35 YEARS AND AN IMAGING (MRI)
OCCASIONAL DRINKER OF AN ALCOHOLIC  ULTRASOUND
 POSITRON EMISSION
BEVERAGES
TOMOGRAPHY (PET)
 BLOOD WORK INDICATED THAT PATIENT
OR PET-CT SCAN
F.V. WAS MILDLY ANEMIC
 FECAL OCULT BLOOD
 HE HAD EXCRUCIATING ABDOMINAL PAIN
AND SEVERE CONSTIPATION, WHICH TEST
PROMPTED HIM TO GO TO THE EMERGENCY
ROOM
 HIS CT SCAN AND MRI REVEALED A MASS
IN THE SIGMOID COLON, DIFFUSE MEDICATIONS
METASTATIC DISEASE IN THE RIGHT AND CHEMO MAY BE USED AT
DIFFERENT TIMES DURING
LEFT LOBES OF THE LIVER AND TREATMENT FOR COLORECTAL
RETROPERITONEAL LYMPHADENOPATHY CANCER:
 HIS COLONOSCOPY REVEALED A  ADJUVANT CHEMO
COMPLETELY OBSTRUCTING 2 CM  NEOADJUVANT CHEMO
DRUGS COMMONLY USED FOR
CIRCUMFERENTIAL MASS IN THE SIGMOID
COLORECTAL CANCER
MEDICAL DIAGNOSIS COLON 20 CM FROM THE ANAL VERGE INCLUDES:
 HIS COLON BIOPSY WAS POSITIVE FOR  5-FLUOROURACIL (5-
STAGE IV COLORECTAL CANCER POORLY DIFFERENTIATED FU)
ADENOCARCINOMA  CAPECITABINE
(XELODA), A PILL THAT
 HIS FINE-NEEDLE ASPIRATION BIOPSY OF IS CHANGED INTO 5-FU
THE LARGEST LIVER LESION WAS POSITIVE ONCE IT GETS TO THE
MEDICAL/SURGICAL HISTORY FOR METASTATIC ADENOCARCINOMA TUMOR.
 HIS FAMILY (SISTER) HISTORY HAD A  IRINOTECAN
(CAMPTOSAR)
PATIENT F.V SEES HIS PRIMARY CARE REPORTED CASE OF HAVING COLON
 OXALIPLATIN (Eloxatin)
DOCTOR, WHO HAD BEEN MANAGING HIS CANCER  TRIFLURIDINE AND
 HE HAS STAGE IV COLORECTAL CANCER, TIPIRACIL (Lonsurf),
HYPERCHOLESTEROLEMIA AND
WHICH IS NOT CURABLE AT THIS TIME
HYPERTENSION
DIAGNOSIS

IMPAIRED BOWEL ELIMINATION

DIAGNOSIS
FEAR AND ANXIETY RELATED TO THREAT

DIAGNOSIS
NURSING

NURSING

NURSING
CHRONIC PAIN MAY BE RELATED TO RELATED TO POOR FLUID INTAKE AS OF DEATH AS EVIDENCED BY CHANGES
SIDE EFFECTS OF VARIOUS CANCER EVIDENCED BY CONSTIPATION IN LIFE EVENT BY HAVING STAGE 4
AGENTS COLON CANCER
SIGNS AND
SYMPTOMS

 ABDOMINAL PAIN

SIGNS AND
SIGNS AND

SYMPTOMS
SYMPTOMS
 FATIGUE  RECTAL BLEEDING
 CHANGE IN BOWEL HABITS  UNEXPLAINED WEIGHT LOSS
 BLOOD IN THE STOOL  ANEMIA
 CONSTIPATION/DIARRHEA

 PROVIDE COMFORT
MEASURES INCLUDING  REVIEW PATIENT PREVIOUS
 CHECK MEDICAL AND BOWEL
MASSAGE, EXPERIENCE WITH CANCER
HISTORY
REPOSITIONING,  ENCOURAGE PATIENT TO
 ENCOURAGE THE PATIENT TO
BACKRUB. TAKE IN FLUID 2000 TO 3000 SHARE THOUGHTS AND
 ASSESSED THE PATIENT’S ML/DAY, IF NOT FEELINGS
INTERVENTION

INTERVENTION
INTERVENTION

PAIN SCALE 8/10 CONTRAINDICATED MEDICALLY.  MAINTAIN FREQUENT

 ASSESS VITAL SIGNS  DETERMINE USIGNS AND CONTACT WITH PATIENT.
ENCOURAGE USE OF TALK WITH AND TOUCH
S

 SYMPTOMSSUAL PATTERN OF

S
S

STRESS MANAGEMENT DEFECATION, COLOR, PATIENT AS APPROPRIATE

SKILLS OR CONSISTENCY, FREQUENCY, AND  PROVIDE ACCURATE,
AMOUNT CONSISTENT INFORMATION
COMPLEMENTARY
 AUSCULTATE BOWEL SOUND REGARDING DIAGNOSIS AND
THERAPIES RELAXATION PROGNOSIS
 MONITOR INPUT AND OUTPUT AND
TECHNIQUES.  ALLOW PATIENT TO EXPRESS
WEIGHT
 ALLOW THE PATIENT TO HIS/HER FEELINGS
 ASSESS VITAL SIGNS
DESCRIBE APPETITE,  ENCOURAGE ADEQUATE FLUID  BE ALERT TO SIGNS OF
BOWEL ELIMINATION, AND INTAKE AND PROVIDE LOW DENIAL AND DEPRESSION
ABILITY TO REST AND RESIDUE DIET
SLEEP.  AVOID FATTY FOODS
EXPECTED OUTCOME
EXPECTED OUTCOME EXPECTED OUTCOME
THE PATIENT WILL BE ABLE TO
THE PATIENT WILL BE ABLE TO DEMONSTRATE A PATIENT WILL MAINTAIN PASSAGE OF DISPLAY APPROPRIATE RANGE OF
SENSE OF RELAXATION AND A SIGN OF RELIEVED SOFT, FORMED STOOL AT A FREQUENCY FEELINGS AND LESSENED FEAR.
PAIN. PERCEIVED AS “NORMAL”.